Cancer immunotherapy has significantly flourished and revolutionized the limited
conventional tumor therapies, on account of its good safety and long-term memory ability …

Macrophages are the gatekeepers of intestinal immune homeostasis as they discriminate
between innocuous antigens and potential pathogens to maintain oral tolerance. However …

Tumor immunotherapy, such as PD-1/PD-L1 blockade, has shown promising clinical efficacy
in patients with various types of tumors. However, the response to PD-1/PD-L1 blockade in a …

The immune microenvironment is crucial for epithelial ovarian cancer (EOC) progression
and consists of tumor-associated macrophages (TAM) and T lymphocytes, such as …

Mammalian cells can release different types of extracellular vesicles (EVs), including
exosomes, microvesicles, and apoptotic bodies. Accumulating evidence suggests that EVs …

The innate immune system provides the first line of defence against foreign microbes and
particulate materials. Engineered nanoparticles can interact with the immune system in …

Tumor-derived exosomes play a pivotal role in regulating tumor progression by mediating
crosstalk between tumor cells and immune cells such as macrophages within the tumor …

Recently, cancer has been considered to be a complex system that includes the tumor
microenvironment (TME). Tumor-associated macrophages (TAMs) are the most common …

This review summarizes the research on phospholipids and their use for drug delivery
related to the Phospholipid Research Center Heidelberg (PRC). The focus is on projects that …

Tumor‐associated macrophages (TAMs) are a complex and heterogeneous population of
cells within the tumor microenvironment. In many tumor types, TAMs contribute toward tumor …